N/A
Completed N=72
iAssist vs. Conventional Instrumentation in Total Knee Arthroplasty
Avascular Necrosis · Post-traumatic; Arthrosis · Knee Osteoarthritis
Source: ClinicalTrials.gov NCT03111407 ↗
Enrolled (actual)
72
Serious AEs
8.3%
Results posted
Apr 2021
Primary outcomePrimary: Component Alignment — 179; 178 degree — p=0.2342
Summary
The purpose of this prospective study is to evaluate Zimmer® iASSIST™ with respect to radiographic, clinical and economic outcomes and compared to conventional instrumentation in primary total knee arthroplasty (NexGen or Persona knee implants).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Component Alignment |
179; 178 | 0.2342 |
| SECONDARY Knee Society Score Assessment |
74.7; 72.4 | 0.4427 |
| SECONDARY Knee Society Score Function |
80.5; 78.5 | 0.6154 |
| SECONDARY EQ-5D Questionnaire |
0.8; 0.8 | 0.4549 |
Eligibility Criteria
Inclusion Criteria
- Patient is male or female
- Patient needs a primary total knee replacement using the NexGen LPS Flex or Persona knee implant
- Patient is diagnosed with non-inflammatory degenerative joint disease (e.g., osteoarthritis, post-traumatic arthritis, avascular necrosis, etc.)
- Patient is over 18 years old
- Patient is able to:
- Understand what participation in the study entails and willing to consent (patient or his/her legal guardian) to participate in the study by signing and dating an IRB/EC (ethics committee) approved inform consent form, and
- Follow surgeon/staff instructions, and
- Return for all follow-up evaluations, and
- Able and willing to undergo a preoperative full-leg, standing radiographs and/or CT-scan
- Patient meets an acceptable preoperative medical clearance and is free of or treated for cardiac, pulmonary, hematological or other conditions that would pose excessive operative risk.
- Patient has a presence of varus or valgus deformity of 15 degrees or less.
Exclusion Criteria
- Patient is currently enrolled in an investigational new drug or device study.
- Patient has an active infection (including septic knee, distant infection, or osteomyelitis).
- Patient has severe hip arthrosis.
- Patient has neurological disorders (including, but not limited to Parkinson's disease).
- Patient has had a prior ipsilateral unicompartmental knee arthroplasty, TKA, knee fusion or patellectomy.
- Patient has hip or knee ankylosis.
- Patient has inflammatory joint disease.
- Patient has rheumatoid knee arthritis.
- Patient has indications of intra- and/or extra-articular deformations that would eliminate or tend to eliminate adequate implant support or prevent the use of an appropriately sized implant, such as polio, history of tibial plateau fracture, etc.
- Patient has any metal within 150 mm of the joint line for the operative-side knee.
- Patient has knee deformities greater than 15 degrees of fixed varus, valgus, or flexion contracture on initial physical examination.
- Female who is pregnant or lactating.
- Patient currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
- Patient has arterial disease or stents that would exclude the use of a tourniquet.
- Patient has insufficient quality or quantity of bone to support the implant due to prior knee surgery (or surgeries), cancer, metabolic bone disease, osteoporosis/osteopenia (diagnosed or treated with medication), active/old/remote infection, etc.
- Patient has a mental condition that may interfere with his/her ability to give an informed consent or interfere with his/her ability or willingness to fulfill the requirements of the study.
- Patient has a condition that would place excessive demands on the implant (e.g., Charcot's joints, muscle deficiencies, multiple joint disabilities, skeletal immaturity, etc.).
- Patient has collateral ligament insufficiency.
- Patient has an immunosuppressive disorder (e.g., AIDS, etc.) that would require cytotoxic drugs, corticosteroids, large dose of irradiation, or antilymphocytic serum.
- Patient has an existing condition that would, in the opinion of the investigator, compromise participation or follow-up in this study.
Data sourced from ClinicalTrials.gov (NCT03111407). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.